{"log_id": 3326136108162520544, "direction": 0, "words_result_num": 28, "words_result": [{"probability": {"variance": 4.7e-05, "average": 0.996116, "min": 0.968797}, "location": {"width": 830, "top": 180, "height": 54, "left": 191}, "words": "磺酰脲类药物与血浆蛋白的结合比例在90%以上,与之相比二甲双胍则很少与血"}, {"probability": {"variance": 0.000109, "average": 0.995646, "min": 0.945695}, "location": {"width": 832, "top": 230, "height": 50, "left": 191}, "words": "浆蛋白结合。二甲双胍可以分布在红细胞里,且分布的量与时间很可能存在函数"}, {"probability": {"variance": 0.003266, "average": 0.988831, "min": 0.65603}, "location": {"width": 830, "top": 277, "height": 52, "left": 194}, "words": "关系。按照常规临床剂量和用法服用盐酸二甲双胍片以后,达到稳态血药浓度的"}, {"probability": {"variance": 0.002611, "average": 0.984789, "min": 0.682358}, "location": {"width": 819, "top": 326, "height": 50, "left": 196}, "words": "时间约为24~48小时,血药浓度一般<1mcg/mL。二甲双胍的对照临床试验表明"}, {"probability": {"variance": 2.8e-05, "average": 0.997456, "min": 0.973819}, "location": {"width": 788, "top": 374, "height": 48, "left": 195}, "words": "即使是服用最高剂量的二甲双胍,药物的最大血药浓度也不会超过5mcg/mL"}, {"probability": {"variance": 0, "average": 0.999685, "min": 0.999449}, "location": {"width": 51, "top": 484, "height": 27, "left": 203}, "words": "代谢"}, {"probability": {"variance": 8.5e-05, "average": 0.991945, "min": 0.974643}, "location": {"width": 148, "top": 528, "height": 30, "left": 204}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.000414, "average": 0.994682, "min": 0.877237}, "location": {"width": 829, "top": 556, "height": 51, "left": 203}, "words": "西格列汀主要以原形通过尿液排泄,体内的代谢只占很少的部分。约有79%的西"}, {"probability": {"variance": 3e-06, "average": 0.998728, "min": 0.993405}, "location": {"width": 291, "top": 616, "height": 38, "left": 203}, "words": "格列汀以原形通过尿液排泄"}, {"probability": {"variance": 0.000169, "average": 0.994704, "min": 0.926081}, "location": {"width": 831, "top": 649, "height": 52, "left": 206}, "words": "口服以C标记的西格列汀以后,约有16%的放射能以西格列汀代谢产物的形式"}, {"probability": {"variance": 6e-06, "average": 0.99824, "min": 0.992208}, "location": {"width": 833, "top": 697, "height": 51, "left": 204}, "words": "排泄。血浆中能够检测到微量水平的6种代谢产物,且这些代谢产物与西格列汀"}, {"probability": {"variance": 0.000208, "average": 0.994337, "min": 0.912828}, "location": {"width": 829, "top": 744, "height": 52, "left": 208}, "words": "抑制血浆DPP-4的行为无关。体外试验表明,与西格列汀的少量代谢过程有关的"}, {"probability": {"variance": 0.001959, "average": 0.983299, "min": 0.769338}, "location": {"width": 512, "top": 800, "height": 43, "left": 209}, "words": "酶主要是CYP3A4,CYP2C8对这一过程也有影响"}, {"probability": {"variance": 0.061613, "average": 0.822874, "min": 0.471838}, "location": {"width": 130, "top": 859, "height": 52, "left": 834}, "words": "下药经"}, {"probability": {"variance": 0.011686, "average": 0.946607, "min": 0.705299}, "location": {"width": 148, "top": 896, "height": 35, "left": 215}, "words": "盐酸二甲双胍"}, {"probability": {"variance": 0.011163, "average": 0.962525, "min": 0.500451}, "location": {"width": 828, "top": 929, "height": 51, "left": 213}, "words": "在正常受试者中开展的二甲双胍静脉内单次给药研究表明,二甲双肌以原形尿"}, {"probability": {"variance": 0.002757, "average": 0.981723, "min": 0.766627}, "location": {"width": 828, "top": 978, "height": 46, "left": 214}, "words": "液排泄,而且既不经过肝脏代谢(人体内没有检测到任何代谢物)也不通过胆十"}, {"probability": {"variance": 0, "average": 0.999383, "min": 0.999147}, "location": {"width": 51, "top": 1043, "height": 27, "left": 214}, "words": "排泄"}, {"probability": {"variance": 4e-05, "average": 0.989954, "min": 0.983624}, "location": {"width": 54, "top": 1130, "height": 28, "left": 218}, "words": "清除"}, {"probability": {"variance": 7.6e-05, "average": 0.995155, "min": 0.975763}, "location": {"width": 147, "top": 1176, "height": 27, "left": 222}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.000295, "average": 0.992503, "min": 0.909834}, "location": {"width": 825, "top": 1208, "height": 46, "left": 220}, "words": "健康受试者口服以C标记的西格列汀],在给药后的一周以内,约100%的放射"}, {"probability": {"variance": 4.6e-05, "average": 0.995777, "min": 0.967599}, "location": {"width": 829, "top": 1256, "height": 43, "left": 219}, "words": "能都通过粪便(13%)和尿液(87%)清除了。口服100mg西格列汀后,药物的"}, {"probability": {"variance": 0.001099, "average": 0.985971, "min": 0.846377}, "location": {"width": 607, "top": 1308, "height": 37, "left": 222}, "words": "表观终末半衰期约为12.4小时,肾脏清除率约为350mL/min"}, {"probability": {"variance": 0.000164, "average": 0.995482, "min": 0.935207}, "location": {"width": 826, "top": 1349, "height": 45, "left": 223}, "words": "西格列汀的清除主要是通过肾脏的排泄并参与了活性肾小管分泌。西格列汀是人"}, {"probability": {"variance": 0.002237, "average": 0.985314, "min": 0.72944}, "location": {"width": 824, "top": 1396, "height": 46, "left": 224}, "words": "有机阴离子转运蛋白-3(hOAT-3)的底物,这种转运蛋白可能参与了西格列汀"}, {"probability": {"variance": 0.000152, "average": 0.994927, "min": 0.942339}, "location": {"width": 805, "top": 1445, "height": 42, "left": 222}, "words": "经肾脏清除的过程。hOAT-3在西格列汀运输过程中的临床关联还不是很清楚"}, {"probability": {"variance": 0.005777, "average": 0.981849, "min": 0.557775}, "location": {"width": 826, "top": 1491, "height": 43, "left": 225}, "words": "西格列汀也是p-糖蛋白的一个底物,这种糖蛋白也可能参与并西格列汀在肾脏的"}, {"probability": {"variance": 0.000707, "average": 0.991277, "min": 0.848807}, "location": {"width": 826, "top": 1537, "height": 44, "left": 223}, "words": "清除。尽管如此,作为p-糖蛋白抑制剂的环孢霉素却并不能降低西格列汀的肾脏"}], "language": 3}